Web notes  

April 2018
FUNDING OPPORTUNITIES- Back

Takeda Pharmaceutical Company Innovators in Science Award

Internal deadline: April 17, 2018

The 2019 Innovators in Science Award will recognize a promising Early-Career Scientist's and an outstanding Senior Scientist's contributions to science in the therapeutic area of Regenerative Medicine and is intended to support their commitment to innovative research.

Eligibility Requirements

The Early-Career Scientist nominee must:

  • Have been engaged in active research for a length of time of 10 years or less since gaining their doctorate degree or equivalent.
  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
  • Currently hold a junior level Post-doctoral or Faculty position.
  • Have made impactful research contributions and show exceptional promise for significant future achievement in the Award field.

In the event that an Early-Career Scientist nominee has taken a maternity, paternity, adoptive, family care, military, or extended sick leave (in line with their current institution's policies) during the 10 years since gaining their doctoral degree or equivalent, they can qualify for an extension of the eligibility timeframe.

The Senior Scientist nominee must:

  • Have been engaged in active research for a length of time of more than 10 years since gaining their doctorate degree or equivalent.
  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
  • Currently hold a senior level Faculty position.
  • Have made multiple, extensive, and impactful research contributions to advance the Award field.

Individuals in receipt of current or prior research support from Takeda Pharmaceutical Company Limited, or its affiliates, are not eligible for nomination.

Interested applicants should submit the following documents:

  1. JHU Limited Submission Cover Sheet
  2. CV of nominee (4 pages), including education, positions, honors and awards and peer-reviewed publications.
  3. Nominee's Research Summary (1,000-word)
  4. Nominee's Future Research Plan (500-word) [required of Early-Career Scientist nominees only]

Questions? Email the Research Development Team at resapp@jhu.edu.


Arnold and Mabel Beckman Foundation Scholars Program

Internal deadline: April 17, 2018

The mission of the Foundation is to make grants to non-profit research institutions to promote research in chemistry and the life sciences, broadly interpreted, and particularly to foster the invention of methods, instruments, and materials that will open up new avenues of research in science.

The purpose of the Beckman Scholars Program is to provide an in-depth, sustained undergraduate research experience in chemistry, biochemistry, biological, and medical sciences, or some interdisciplinary combination of these subjects, for exceptionally talented, full-time undergraduate students at accredited US four-year colleges and universities; young people who ultimately will become prominent leaders in their scientific and professional pursuits.

The Program's financial support for a student and mentor over 15 continuous months of research, in conjunction with the Annual Beckman Symposium, offers an academically stimulating and unique educational experience. The Program encourages the participation of both junior, as well as more senior academics to serve as Faculty Mentors.

JHU, as an institution, can apply if at least 12 faculty members become mentors. Interested applicants should submit the following documents to resapp@jhu.edu:

  1. JHU Limited Submission Cover Sheet
  2. Mentor Statement (1 page), in first person voice, briefly describe your proposed Scholar Mentorship Plan. How will the Scholar be mentored? What is the frequency and nature of planned interactions? List current UG in your lab.
  3. CV of mentor (2 pages), include honors and awards, professional experience, education and training and up to 10 most recent publications; underline undergraduate co-authors in publication list.

Questions? Email the Research Development Team at resapp@jhu.edu


Michael J. Fox Foundation (MJFF) Challenge

No application deadline

The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly.

The ability to image alpha-synuclein deposition in the brain would be a game-changing achievement for the Parkinson's disease (PD) field. The accumulation of aggregated alpha-synuclein is a pathological hallmark of PD and a priority target for drug development given its hypothesized contribution to neurodegeneration. In vivo imaging of alpha-synuclein pathology could be useful as a biomarker of the presence of disease and disease progression and as a pharmacodynamic tool for drug development. With this prize, the Foundation seeks to attract research teams and accelerate momentum to speed the development of such a tracer.

Contestants: Anyone is eligible for the prize who agrees to all contest rules. Contestants may be MJFF funded or not and can be from either academia or industry.

Contest rules:

  1. Contestants must apply for the prize with pre-clinical and clinical data supporting the broad use of their alpha-synuclein radiotracer. Judges may ask for additional data, including but not limited to raw imaging data.
  2. NOTE: All contestants must agree to make the winning radiotracer available for use by The Michael J. Fox Foundation and MJFF awardees through a nonexclusive license or other MJFF-approved mechanism.

Criteria for winning: The winning contestant must demonstrate that the radiotracer binds with relatively high selectivity to alpha-synuclein according to pre-specified criteria and must demonstrate proof-of-concept in human subjects, including people with Parkinson's disease and/or another synucleinopathy. See below for more details on submission requirements.

Timeline: There is no deadline for submissions. The $2 million award will be issued to the first contestant who submits compelling evidence of a viable selective tracer and agrees to its widespread use. If no award is given by mid-2018, The Michael J. Fox Foundation will evaluate the state of the field and utility of such a prize.


Return to top of Funding Opportunities

 
   
April 2018 articles:
Training Sessions: Relying on an External IRB (JHM IRB)
Fee Schedule Adjustment for Hospital Services Charged to Clinical Trial Budgets
Change in Federalwide Assurance [FWA] Numbers
Changes to NIH-funded Human Subjects Research
Free Resources for Longitudinal Clinical Research Studies
NIH requirement for Single IRB (sIRB)
JHM IRB Reliance Requests
Sharing Partnership for Innovative Research in Translation
Johns Hopkins Institute for Clinical and Translational Research
Johns Hopkins Research Network
 
Visit Animal Care and Use Committee Website
Current Classes
"Interinstitutional Assurance" Agreement
Health, Safety, and Environment (HSE) presents: Safety in Research Updates
Takeda Pharmaceutical Company Innovators in Science Award
Arnold and Mabel Beckman Foundation Scholars Program
Michael J. Fox Foundation (MJFF) Challenge
Why Project Outcomes Matter in your Interim and Final Research Performance Progress Report (RPPR)
NIH Matchmaker, A Tool For Finding Similar NIH Projects
NIH Video Tutorials on How to Apply for Grants
NIH Policy: Foreign Components Added to a Grant to a Domestic or Foreign Organization

This Month's Departmental Listings

Upcoming Deadlines for April, May and June

April Events at the Genetic Resources Core Facility
       

 

JHM AppointmentsEmployment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM 

 

                                                                                                                                                           The Web Center